HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular characterization of human skin response to diphencyprone at peak and resolution phases: therapeutic insights.

Abstract
Diphencyprone (DPCP) is a hapten that induces delayed-type hypersensitivity (DTH) reactions. It is used as an immune-modulating therapeutic, but its molecular effects in human skin are largely unknown. We studied cellular and molecular characteristics of a recall response to 0.04% DPCP at 3-day (peak) and 14-day (resolution) time points using immune markers, reverse-transcriptase-PCR (RT-PCR), and gene array approaches. A peak response showed modulation of ∼7,500 mRNA transcripts, with high expression of cytokines that define all major effector T-cell subsets. Concomitant increases in T-cell and CD11c+ dendritic cell (DC) infiltrates were measured. The resolution reaction was characterized by unexpectedly high levels of T cells and mature (DC-lysosome-associated membrane glycoprotein positive (DC-LAMP+)) DCs, but with marked decreases in expression of IL-2, IFNγ, and other T cell-derived cytokines. However, negative immune regulators such as IDO1 that were high in peak reactions, continued to have high expression in resolution reactions. In the resolution reaction, ∼1,500 mRNA transcripts were significantly different from placebo-treated skin. These data suggest that the response to DPCP evolves from an inflammatory/effector peak at day 3 to a more regulated immune response after 14 days. This model system could be useful for further dissection of mechanisms of immune activation or negative immune regulation in human skin.
AuthorsNicholas Gulati, Mayte Suárez-Fariñas, Judilyn Fuentes-Duculan, Patricia Gilleaudeau, Mary Sullivan-Whalen, Joel Correa da Rosa, Inna Cueto, Hiroshi Mitsui, James G Krueger
JournalThe Journal of investigative dermatology (J Invest Dermatol) Vol. 134 Issue 10 Pg. 2531-2540 (Oct 2014) ISSN: 1523-1747 [Electronic] United States
PMID24751728 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Cyclopropanes
  • Cytokines
  • Haptens
  • IDO1 protein, human
  • Immunologic Factors
  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • diphenylcyclopropenone
Topics
  • Adult
  • Biopsy
  • Cyclopropanes (pharmacology)
  • Cytokines (metabolism)
  • Dose-Response Relationship, Drug
  • Female
  • Haptens (pharmacology)
  • Humans
  • Immunity, Cellular (drug effects)
  • Immunologic Factors (pharmacology)
  • Indoleamine-Pyrrole 2,3,-Dioxygenase (metabolism)
  • Langerhans Cells (drug effects, pathology)
  • Male
  • Middle Aged
  • Skin (drug effects, metabolism, pathology)
  • T-Lymphocytes (drug effects, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: